Valuation : Avicanna Inc.

Market Cap 14.46M 10.47M 9M 8.48M 7.73M 996M 14.52M 100M 38.75M 509M 39.33M 38.48M 1.61B P/E 2024
-8.43x
P/E 2025 -9.36x
Enterprise Value 14.18M 10.27M 8.83M 8.32M 7.58M 977M 14.23M 98.46M 38M 499M 38.56M 37.74M 1.58B EV / Sales 2024
1.31x
EV / Sales 2025 1.03x
Free-Float
78.71%
Yield 2024 *
-
Yield 2025 -
1 day+4.76%
1 week-12.00%
Current month-15.38%
1 month-18.52%
3 months-4.35%
6 months-40.54%
Current year-51.11%
1 week 0.1
Extreme 0.105
0.13
1 month 0.1
Extreme 0.105
0.14
Current year 0.1
Extreme 0.095
0.24
1 year 0.1
Extreme 0.095
0.3
3 years 0.1
Extreme 0.095
0.6
5 years 0.1
Extreme 0.095
1.01
10 years 0.1
Extreme 0.095
7.4
Manager TitleAgeSince
Sales & Marketing - 01/05/2015
Chief Executive Officer 39 26/11/2016
Director of Finance/CFO - 15/09/2025
Director TitleAgeSince
Chairman 39 26/11/2016
Director/Board Member - 22/10/2018
Director/Board Member - 01/01/2026
Date Insider Type Main position Quantity % Market Cap. Importance
12/06/26 Sell

Director

333,000 0.2647%
27/05/26 Buy

Director

160,000 0.1272%
26/05/26 Buy

Director

150,000 0.1192%
Change 5-day change 1-year change 3-year change Capi.($)
+4.76%-12.00%-59.26%-73.81% 10.5M
-3.24%-6.89%-5.65%+11.20% 48.01B
+0.17%-1.04%+405.80%+546.58% 44.44B
-0.86%-0.53%+36.92%+20.35% 42.67B
-0.14%-2.13%+1.31%+82.21% 39.96B
0.00%-2.61%+13.09%+42.33% 32.75B
-3.44%+0.22% - - 17.74B
-0.78%+0.53%+19.14%+116.26% 16.49B
-0.37%-0.87%+10.98%+30.93% 14.38B
-0.86%-1.41%+71.82%+39.36% 13.4B
Average -0.48%-2.08%+54.91%+90.60% 26.98B
Weighted average by Cap. -1.04%-1.10%+84.30%+131.91%

Financials

2024 2025
Net sales 25.46M 18.44M 15.85M 14.94M 13.62M 1.75B 25.56M 177M 68.22M 896M 69.24M 67.76M 2.83B 25.48M 18.45M 15.87M 14.95M 13.63M 1.76B 25.58M 177M 68.28M 897M 69.29M 67.81M 2.83B
Net income -3.62M -2.62M -2.25M -2.12M -1.93M -249M -3.63M -25.12M -9.69M -127M -9.84M -9.63M -402M -2.76M -2M -1.72M -1.62M -1.48M -190M -2.77M -19.16M -7.39M -97.12M -7.5M -7.34M -307M
Net Debt -339K -245K -211K -199K -181K -23.34M -340K -2.35M -908K -11.93M -921K -902K -37.67M -281K -203K -175K -165K -150K -19.34M -282K -1.95M -752K -9.88M -763K -747K -31.2M
Logo Avicanna Inc.
Avicanna Inc. is a commercial-stage international biopharmaceutical company. It focuses on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Its products and services are grouped into four main categories, such as medical cannabis products; MyMedi.ca medical cannabis platform; pharmaceutical pipeline; and active pharmaceutical ingredients. The formulary of proprietary medical cannabis products is marketed under the RHO Phyto brand and offers a range of scientifically driven formulations in a variety of products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca offers a diverse portfolio of products and bilingual pharmacist-led patient support programs. It has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. Trunerox is its oral formulation.
Employees
112
Date Price Change Volume
09/09/26 CA$0.1100 +4.76% 120,785
08/09/26 CA$0.1050 -19.23% 398,041
04/09/26 CA$0.1300 +8.33% 74,002
03/09/26 CA$0.1200 0.00% 280,101
02/09/26 CA$0.1200 -4.00% 63,725
  1. Stock Market
  2. Stocks
  3. AVCN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!